Treatment Trials

5 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
      Description

      This study is to collect safety and immunogenicity data for an Rift Valley Fever (RVF) vaccine

      Conditions
      Rift Valley Fever
      Talk to us
      COMPLETED
      Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
      Description

      This study is designed to determine the safety and immunogenicity of an inactivated Rift Valley Fever (RVF) Vaccine in adults

      Conditions
      Rift Valley Fever
      Talk to us
      COMPLETED
      Safety and Immunogenicity Study of Rift Valley Fever Vaccine
      Description

      This study is designed to determine the safety and immunogenicity of a Rift Valley Fever (RVF) Vaccine

      Conditions
      Rift Valley Fever
      Talk to us
      COMPLETED
      Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
      Description

      This study is to determine if a vaccine for Rift Valley Fever (RVF) is safe to give to humans. The study will examine how well the vaccine (RVF MP-12) stimulates the body's immune response (which fights off infection) and if the vaccine is stable or if the virus used to make the vaccine changes into a different form once injected into the body. Twenty healthy volunteers (18-50 years old) will be vaccinated with a single dose of undiluted RVF MP-12, injected into a muscle.

      Conditions
      Rift Valley Fever
      Talk to us
      RECRUITING
      Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011
      Description

      Phase 1 randomized, double-blind, placebo-controlled trial to evaluate safety, tolerability, pharmacokinetics (PK) and immunogenicity of IDB-011 following intramuscular (IM )administration of single ascending doses to healthy adult participants.

      Conditions
      Rift Valley Fever
      Talk to us